EURopean wide Innovative Procurement of Health Innovation
Public Procurement Organizations (PPO) are rethinking existing practices as currently, quality of care is compromised and they do not lead to economic most advantageous purchasing.
PPO involved in different PPI/PCP are teaming up...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto EURIPHI
Duración del proyecto: 19 meses
Fecha Inicio: 2018-12-08
Fecha Fin: 2020-07-31
Líder del proyecto
MEDTECH EUROPE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
2M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Public Procurement Organizations (PPO) are rethinking existing practices as currently, quality of care is compromised and they do not lead to economic most advantageous purchasing.
PPO involved in different PPI/PCP are teaming up around a novel approach of Value Based Procurement (VBP) joined by national/regional procurement organizations and service providers with a common vision, a value based procurement of innovative solutions to enable the needed transformation of health and social care delivery. The EURIPHI consortium involves 14 PPO, 10 with a regional or national remit and service providers from 6 countries who together, procure for more than 200 care service providers. The European Health Public Procurement Alliance members are also contributing to the project. This provides a strong basis to build out a Value Based PPI Community of Practice (CoP) to successfully achieve one of the key objectives of the CSA.
The EURIPHI common vision is to build out around a MEAT VBP framework which will be made accessible with adaptions necessary to support the cross-border PPI leading to MEAT Value Based PPI. Cross-border PPI-Legal guidance will be developed by legal expert partners.
Innovative solutions will be identified in the fields of rapid diagnostic (RD) tools in infectious disease and in the most promising integrated care services (IC). The identification of specific demands and prioritization will be done by expert partners and through the establishment of the Health Regional Network including stakeholders.
Following an open market consultation, case testing will be performed for 1-2 RD and 3-4 IC innovative solutions and serve as an input for the PPI or PCP writing of SC1-BHC-20-2020.
Dissemination and exploitation will be done by partners with a European or International remit and by an involvement of all partners in a blog series and EURIPHI Insights, with the support of a permanent secretariat.